Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2021

View Archived Issues

Phase I data presented for SHR-1701 in patients with NSCLC

Enrollment opens in phase IIa study of FM-101 for NAFLD and NASH

Preclinical data reported on MigVax-101 subunit oral vaccine for COVID-19

Spark Therapeutics patents compositions for secretable protein-induced immune tolerization

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Yuhan Corp., Green Cross Corp. present new GLCT-1 inhibitors

Zhejiang Hisun Pharmaceutical divulges new RET and/or VEGFR-2 inhibitors

New HBV HBsAg secretion inhibitors synthesized at Arbutus Biopharma

Penpulimab is highly active in relapsed/refractory classical Hodgkin's lymphoma

Targovax presents 24-month data from phase I/II study of ONCOS-102 in mesothelioma

China's NMPA approves clinical trial application for sirolimus for injection (albumin-bound)

First patient dosed in phase I study of CID-103 in multiple myeloma

Sovateltide slows down the progression of Alzheimer's disease in phase II study

Berdazimer sodium shows promising efficacy in preclinical SARS-CoV-2 transmission model

Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

Phase I data for seclidemstat in R/R Ewing sarcoma

Myelin renewal reverses AD cognitive dysfunction in mice

Circulating markers of collagen turnover tied to disease severity in ADPKD

Phase II proof-of-concept study of VX-864 in AATD meets primary endpoint

HiberCell begins phase Ia study of PERK inhibitor HC-5404-FU in metastatic solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...